Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer
AUSTIN, Texas, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Astrotech Corporation ( Nasdaq: ASTC ) ( the "Company" or "Astrotech" ) , today announced that it has appointed Nihanth Badugu as Chief Operating Officer ( "COO" ) of the Company. Mr. Badugu's appointment is effective as of August 13, 2025.
A Closer Look at Thermo Fisher Scientific's Options Market Dynamics - Thermo Fisher Scientific ( NYSE:TMO )
Investors with a lot of money to spend have taken a bearish stance on Thermo Fisher Scientific TMO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Beat the Market the Zacks Way: CBRE, Acadian, Fastenal in Focus
CBRE, Acadian, and Fastenal highlight Zacks' market-beating picks as portfolios outpace broader indexes with strong 2025 gains.
TMO Receives FDA Approval for Oncomine Dx Target Test
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Toast, Amazon, Thermo Fisher Scientific On CNBC's 'Final Trades' - TransDigm Gr ( NYSE:TDG ) , Amazon.com ( NASDAQ:AMZN )
On CNBC's "Halftime Report Final Trades," Ritholtz Wealth Management CEO Joshua Brown named Toast, Inc. TOST following the release of quarterly results. On Aug. 5, the company reported quarterly earnings of 13 cents per share. It exceeded the analyst consensus estimate of 11 cents per share.
Banzai Appoints Matt McCurdy as Vice President of Sales to Drive Strategic Growth of AI-Enabled Marketing and Sales Solutions to Enterprise Customers
SEATTLE, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- ( NASDAQ: BNZI ) ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, today announced the appointment of Matt McCurdy as Vice President of Sales to lead strategic growth and ...
[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "AI in Synthetic Biology Market Size, Trends and Insights By Technology ( Gene Synthesis, Genome Editing, Synthetic Biology Tools, Bioinformatics ) , By Application ( Healthcare ...
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings ...
Why Is Avantor Stock Surging Monday? - Avantor ( NYSE:AVTR )
Engine estimates Avantor's strategic value at $17-$19 per share, a 50% premium. LSS margins trail Thermo Fisher's comparable division by 450 basis points. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off → Avantor Inc.
Veterinary Diagnostics Market is expected to generate a revenue of USD 4.52 Billion by 2031, Globally, at 6.59% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Veterinary Diagnostics Market Size is projected to grow at a CAGR of 6.59% from 2024 to 2031, according to a new report published by Verified Market Research®.
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
Allergy Diagnostics and Treatments Market to Reach $96.4 Billion by 2030
Boston, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Global Markets for Allergy Diagnostics and Treatments" is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 7.3% from ...
Banzai to Host Second Quarter 2025 Financial Results Conference Call on Thursday, August 14, 2025 at 4:30 p.m. Eastern Time
SEATTLE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- ( NASDAQ: BNZI ) ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, will hold a conference call on Thursday, August 14, 2025, at 4:30 p.m.
Banzai to Host Second Quarter 2025 Financial Results Conference Call on Thursday, August 14, 2025 at 4:30 p.m. Eastern Time - Banzai International ( NASDAQ:BNZI )
SEATTLE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- Banzai International, Inc. BNZI ( "Banzai" or the "Company" ) , a leading marketing technology company that provides essential marketing and sales solutions, will hold a conference call on Thursday, August 14, 2025, at 4:30 p.m.
Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service - Trinity Biotech ( NASDAQ:TRIB )
FDA-cleared PreClara™ Ratio ( sFlt-1/PlGF ) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes
Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service
FDA-cleared PreClara™ Ratio ( sFlt-1/PlGF ) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes ...
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update
JENA, Germany, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- InflaRx N.V. ( Nasdaq: IFRX ) , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its financial results for the three months ended June 30, 2025, and provided a business ...
Seer ( SEER ) Q2 Revenue Jumps 32%
Seer ( NASDAQ:SEER ) , a life sciences technology firm specializing in advanced proteomics, released its second quarter results for fiscal 2025 on August 6, 2025. Seer reported GAAP revenue of $4.1 million, topping consensus estimates of $3.75 million by $0.35 million and marking a 32% increase ...
Seer ( SEER ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Aug. 6, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 1.59% on an annualized basis producing an average annual return of 13.23%. Currently, Thermo Fisher Scientific has a market capitalization of $175.96 billion.
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Fortrea ( Nasdaq: FTRE ) , a leading global contract research organization ( CRO ) , today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue ...
Beat the Market the Zacks Way: Oracle, Credo Tech, Palantir in Focus
Oracle, Credo Tech, and Palantir shine in volatile markets, leading Zacks portfolios with standout gains and upgraded outlooks.
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
CI's Q2 earnings benefit from strong Evernorth Health Services unit, offsetting customer losses and rising costs. It continues to expect 2025 adjusted EPS at a minimum of $29.60.
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 1.45% on an annualized basis producing an average annual return of 13.22%. Currently, Thermo Fisher Scientific has a market capitalization of $177.93 billion.
Thermo Fisher Posts 3% Q2 Rise
Thermo Fisher Scientific ( NYSE:TMO ) , a leading provider of scientific instrumentation, reagents and consumables, and specialty diagnostics, reported its second quarter results for fiscal 2025 on July 23, 2025. The company delivered higher revenue and non-GAAP earnings per share than Wall ...
Unpacking the Latest Options Trading Trends in Thermo Fisher Scientific - Thermo Fisher Scientific ( NYSE:TMO )
Deep-pocketed investors have adopted a bearish approach towards Thermo Fisher Scientific TMO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week ( July 21-July 25 ) : Are The Others In Your Portfolio? - Astera Labs ( NASDAQ:ALAB ) , Baker Hughes ( NASDAQ:BKR )
Medpace surged over 137% after crushing Q2 earnings estimates. Strong earnings and raised guidance drove sharp gains in pharma and tech names. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily. These ten large-cap stocks were top performers last week.
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 20 years by 6.48% on an annualized basis producing an average annual return of 14.98%. Currently, Thermo Fisher Scientific has a market capitalization of $181.46 billion.
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, July 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "CRISPR Gene Editing Market Size, Trends and Insights By Product ( Kits and Reagents, Services ) , By Gene Editing Modality ( Ex-Vivo Editing, In-Vivo Editing ) , By Technology ...
Company News for Jul 24, 2025
Companies In The News Are: T, TMO, GD, BSX.
Thermo Fisher Posts 3% Q2 Revenue Gain
Thermo Fisher Scientific ( NYSE:TMO ) , a leader in life sciences tools and diagnostics, reported its second quarter 2025 results on July 23, 2025. The company outpaced expectations on both revenue and non-GAAP EPS, delivering $10.85 billion in revenue and $5.36 in non-GAAP EPS versus analyst ...
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views - Abivax ( NASDAQ:ABVX ) , Alpha Modus Holdings ( NASDAQ:AMOD )
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 points on Wednesday. The Dow traded up 0.82% to 44,869.16 while the NASDAQ rose 0.16% to 20,925.86. The S&P 500 also rose, gaining, 0.44% to 6,337.46. Industrials shares jumped by 1.1% on Wednesday.
Why Thermo Fischer Stock Is Rising Wednesday - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Q2 earnings of $5.36/share beat estimates of $5.23; revenue rose 3% YoY to $10.86 billion. 2025 revenue guidance raised to $43.6 billion-$44.2 billion; EPS forecast increased to $22.22-$22.84.
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma ( NASDAQ:ARWR ) , Abivax ( NASDAQ:ABVX )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday. Shares of GE Vernova Inc. GEV rose sharply during Wednesday's session after the company posted better-than-expected second-quarter 2025 earnings and raised its full-year guidance.
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market
TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.
Rapid7 Labs Security Researchers to Speak at Black Hat USA 2025 and DEF CON 33
Rapid7 Labs researchers speaking at Black Hat and DEF CON will share knowledge that represents the company's 25 years of security program expertise.
Thermo Fisher Scientific ( TMO ) Tops Q2 Earnings and Revenue Estimates
Thermo Fisher (TMO) delivered earnings and revenue surprises of +2.68% and +1.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Behind the Scenes of Thermo Fisher Scientific's Latest Options Trends - Thermo Fisher Scientific ( NYSE:TMO )
Financial giants have made a conspicuous bullish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific TMO revealed 49 unusual trades. Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies.
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca ( NASDAQ:AZN )
AstraZeneca plans $50 billion in U.S. investment by 2030, including a drug facility in Virginia for its metabolic and weight loss portfolio. Company aims to generate 50% of $80 billion revenue from the U.S. by 2030 with new manufacturing and R&D expansions.
ISRG Stock Before Q2 Earnings Release: To Buy or Not to Buy?
Intuitive Surgical's second-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing - Biogen ( NASDAQ:BIIB )
Biogen to invest $2 billion more in its RTP manufacturing, adding to $10B already spent in North Carolina. Expansion includes advanced automation, AI integration and multi-platform fill finish capabilities.
Thermo Fisher ( TMO ) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus
Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.
Thermo Fisher Scientific's Options: A Look at What the Big Money is Thinking - Thermo Fisher Scientific ( NYSE:TMO )
Deep-pocketed investors have adopted a bullish approach towards Thermo Fisher Scientific TMO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Rep. Rick Allen Has Bought Up to $15K Worth Of Intuit Stock: Here's What You Should Know - Netflix ( NASDAQ:NFLX ) , Intuit ( NASDAQ:INTU )
An official report on July 15, 2025 reveals Representative Rick Allen's recent purchase of Intuit INTU stock, valued between $1,001 and $15,000. The transaction took place on June 20, 2025, as per the July filing. At this time, Intuit shares are trading down 0.22% at $744.34.
Analysts Estimate Thermo Fisher Scientific ( TMO ) to Report a Decline in Earnings: What to Look Out for
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Peering Into Thermo Fisher Scientific's Recent Short Interest - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific's TMO short percent of float has fallen 10.0% since its last report. The company recently reported that it has 4.41 million shares sold short, which is 1.17% of all regular shares that are available for trading.
In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
